Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.

Stopped due to low recruitment rate that would have led to a long study duration.

Conditions

• Lymphoma, Large Cell, Diffuse

Interventions

• DRUG: Zevalin

Sponsor

Spectrum Pharmaceuticals, Inc

Collaborators

• [object Object]